ARVN
presentationj
Tuesday, June 2, 2026 BiopharmaWatch Research 1 min read Key Takeaway: presentationj
Price reaction · baseline $8.58 (2026-06-01 close) · hit after-hours · 1 other ARVN headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+12%
120-day peak, hindsight
Typical move
4%
average across 9 past catalysts
Cash runway
~35 mo
Low dilution risk
Lead asset
ARV-110
Phase 1 · Prostate Cancer Metastatic
Full Press Release Details